uniQure Overview

Life ScienceCompany

Was uniQure formerly PE-backed?

Yes. uniQure was formerly owned by 2 private investors.

Where is uniQure headquartered?

uniQure is headquartered in Amsterdam, Netherlands.

What is uniQure’s revenue?

uniQure disclosed revenue of 27M USD for 2024 and 16M USD for 2023.

How many employees does uniQure have?

uniQure has 209 employees.

What sector is uniQure in?

uniQure is a life science company.

When was uniQure founded?

uniQure was founded in 1998.

uniQure

uniQure N.V.

Paasheuvelweg 25a,
Amsterdam, 1105 BP
Netherlands,
+31 20 240 6000
www.uniqure.com

uniQure is a gene therapy company that developed the first and only gene therapy product to receive regulatory approval in the European Union. Gene therapy is a technique for correcting defective or missing genes that cause diseases. uniQure is primarily focused on rare genetic diseases, and will also start developing gene therapies for chronic and degenerative diseases that affect larger populations. uniQure was founded in 1998 and is based in Amsterdam, Netherlands.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # 2 1 - - - - 3
vol $3M $52M $56M
Sell (0.0/yr) # - - - - - - 0
  3

Top M&A Advisors

Legal Deals
Morgan Lewis
1

Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.